1 – 1 of 1
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Clinical proof of concept study (blossom) shows novel beta 3 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder
(2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.239-239
- Contribution to journal › Published meeting abstract